Meredith S Eno

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 15, 2022
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.

Meredith S Eno, Jason D Brubaker, John E Campbell

Pageof 1

Frequent Collaborators

1 joint publications

Kevin Wilson